RECURSION PHARMACEUTICALS, INC. Undistributed Earnings, Basic
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Undistributed Earnings, Basic of -$44.76 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes › Earnings Per Share
us-gaap:UndistributedEarnings · last filed 2021-11-10
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, basic for the quarter ending 2021-09-30 was -$44.76M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, basic for the quarter ending 2021-06-30 was -$40.43M.
| Period end | Undistributed Earnings, Basic 3 month | Undistributed Earnings, Basic 6 month |
|---|---|---|
| 2021-09-30 | -$44.76M 10-Q · filed 2021-11-10 | -$85.19M derived: sum of 2 quarters · filed 2021-11-10 |
| 2021-06-30 | -$40.43M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |